I agree, however I'm not sure if Leo's top priority right now is to chase institutional funding. It doesn't appear (to me) that funding is necessarily a huge discussion right now. They seem to be doing just fine without needing a huge infusion of cash. I'm sure when the trials are in a more mature state, uplisting will be bigger discussion point but I just don't see it right now.
Cabel, the NYSE is more expensive per year than NASDQ. Based on how Leo has handled finances so far I'd bet he is shooting for the NAS to minimize operating costs in the future. He is a good stewart of the company's money.
Market Data 
Markets 
AI
